Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types

Conditions:   Non Small Cell Lung Cancer;   Hepatocellular Carcinoma;   Melanoma;   Renal Cell Carcinoma;   Microsatellite Instability High;   Mismatch Repair Deficiency;   Mesothelioma;   Esophageal Squamous Cell Carcinoma;   Squamous Cell Carcinoma of Head and Neck;   Urothelial  Carcinoma;   Cervical Cancer Interventions:   Drug: MT-8421;   Drug: Nivolumab Sponsor:   Molecular Templates, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials